trending Market Intelligence /marketintelligence/en/news-insights/trending/cd6qnRTjMjVmZV9iQvFPoA2 content esgSubNav
In This List

OncBioMune Pharmaceuticals names CEO

Blog

Insight Weekly: Ukraine war impact on mining; US bank growth slowdown; cloud computing headwinds

Blog

Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall

Blog

Global M&A By the Numbers: Q1 2022

Blog

Insight Weekly: Challenges for European banks; Japan's IPO slowdown; carmakers' supply woes


OncBioMune Pharmaceuticals names CEO

OncBioMune Pharmaceuticals Inc. appointed Brian Barnett to replace Jonathan Head as CEO of the company, effective Dec. 26.

Head will continue to serve as OncBioMune's board chairman and was appointed chief scientific officer.

Before joining OncBioMune, Barnett had served at Puma Biotechnology Inc. as vice president and head of medical affairs since August 2016.

Baton Rouge, La.-based OncBioMune Pharmaceuticals is a clinical-stage biopharmaceutical company that develops cancer immunotherapy products.